{"entity":{"type":"insider","cik":"0001384607","url":"/insider/0001384607","json_url":"/insider/0001384607.json","name":"LVP GP I, LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":1,"first":"2013-07-23","last":"2013-07-23","span_basis":"filed_date"},"name_variants":[{"name":"LVP GP I, LLC","source":"filing","n_filings":1,"first_seen":"2013-07-23","last_seen":"2013-07-23"}],"transactions":[{"id":4481660,"accession":"0001181431-13-041163","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001181431-13-041163","line_url":"/filing/0001181431-13-041163#line-17","is_derivative":false,"issuer_cik":"0001165583","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001165583","owner_cik":null,"owner_name":"LVP GP I, LLC; LATTERELL PATRICK F; LVP Life Science Ventures I, L.P.; LVP GP III, LLC; LVP III Associates, L.P.; LVP Life Science Ventures II, L.P.; LVP III Partners LP; LVPMC, LLC; LVP GP II, LLC; LVP LIFE SCIENCE VENTURES III L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":43223.0,"shares_display":"43,223","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":734791.0,"total_display":"734,791.00","shares_owned_after":1348212.0,"shares_owned_after_display":"1,348,212","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-07-23","filed_date":"2013-07-23","scope":"insider"},{"id":4481656,"accession":"0001181431-13-041163","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001181431-13-041163","line_url":"/filing/0001181431-13-041163#line-16","is_derivative":false,"issuer_cik":"0001165583","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001165583","owner_cik":null,"owner_name":"LVP GP I, LLC; LATTERELL PATRICK F; LVP Life Science Ventures I, L.P.; LVP GP III, LLC; LVP III Associates, L.P.; LVP Life Science Ventures II, L.P.; LVP III Partners LP; LVPMC, LLC; LVP GP II, LLC; LVP LIFE SCIENCE VENTURES III L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":33834.0,"shares_display":"33,834","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":575178.0,"total_display":"575,178.00","shares_owned_after":1055363.0,"shares_owned_after_display":"1,055,363","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-07-23","filed_date":"2013-07-23","scope":"insider"},{"id":4481651,"accession":"0001181431-13-041163","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001181431-13-041163","line_url":"/filing/0001181431-13-041163#line-15","is_derivative":false,"issuer_cik":"0001165583","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001165583","owner_cik":null,"owner_name":"LVP GP I, LLC; LATTERELL PATRICK F; LVP Life Science Ventures I, L.P.; LVP GP III, LLC; LVP III Associates, L.P.; LVP Life Science Ventures II, L.P.; LVP III Partners LP; LVPMC, LLC; LVP GP II, LLC; LVP LIFE SCIENCE VENTURES III L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7937.0,"shares_display":"7,937","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":134929.0,"total_display":"134,929.00","shares_owned_after":247555.0,"shares_owned_after_display":"247,555","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-07-23","filed_date":"2013-07-23","scope":"insider"},{"id":4481647,"accession":"0001181431-13-041163","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001181431-13-041163","line_url":"/filing/0001181431-13-041163#line-14","is_derivative":false,"issuer_cik":"0001165583","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001165583","owner_cik":null,"owner_name":"LVP GP I, LLC; LATTERELL PATRICK F; LVP Life Science Ventures I, L.P.; LVP GP III, LLC; LVP III Associates, L.P.; LVP Life Science Ventures II, L.P.; LVP III Partners LP; LVPMC, LLC; LVP GP II, LLC; LVP LIFE SCIENCE VENTURES III L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2161.0,"shares_display":"2,161","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":36737.0,"total_display":"36,737.00","shares_owned_after":67409.0,"shares_owned_after_display":"67,409","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-07-23","filed_date":"2013-07-23","scope":"insider"},{"id":4481645,"accession":"0001181431-13-041163","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001181431-13-041163","line_url":"/filing/0001181431-13-041163#line-13","is_derivative":false,"issuer_cik":"0001165583","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001165583","owner_cik":null,"owner_name":"LVP GP I, LLC; LATTERELL PATRICK F; LVP Life Science Ventures I, L.P.; LVP GP III, LLC; LVP III Associates, L.P.; LVP Life Science Ventures II, L.P.; LVP III Partners LP; LVPMC, LLC; LVP GP II, LLC; LVP LIFE SCIENCE VENTURES III L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1080.0,"shares_display":"1,080","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":18360.0,"total_display":"18,360.00","shares_owned_after":33703.0,"shares_owned_after_display":"33,703","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-07-23","filed_date":"2013-07-23","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001302573","name":"OncoMed Pharmaceuticals Inc","url":"/issuer/0001302573","role":"Ten percent owner","n_filings":1,"first_seen":"2013-07-23","last_seen":"2013-07-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001384607","retrieved_at":"2026-08-21T23:18:57+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}